Sign in to view content

First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability

Pravin U. Dugel, MD

Video
Published 2019

Pravin U. Dugel, MD

AMD Neovascular Part II Symposium

Related

Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact
John D Pitcher, MD
On Demand Cases, Courses, and Papers
2017
Wet AMD 2 Symposium
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more